AEGiS-UPI: Syphilis down among women, their infants United Press InternationalImportant note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Syphilis down among women, their infants

United Press International - Thursday, 12 July 2001
Mike Cooper, UPI Science News


ATLANTA, July 12 (UPI) -- The number of syphilis cases among newborn infants declined by more than half since 1997 as fewer women of childbearing age were infected with the sexually transmitted disease, federal health officials said Thursday.

Pregnant women with syphilis can pass the disease on to their unborn children, many of whom die before birth or shortly after birth, the Centers for Disease Control and Prevention said. Infants who live can suffer developmental problems, seizures, blindness, deafness or retardation.

The CDC reported there were 529 reported cases of congenital syphilis, where the disease is passed from mother to child during pregnancy or delivery, in the United States last year. That was a 51 percent reduction from the 1,077 cases reported in 1997.

The syphilis rate among women aged 15 to 44 declined 38 percent during the same period, researchers said.

"With this decline in congenital syphilis, we have substantially improved infant health in the United States," CDC Director Dr. Jeffrey Koplan said.

Despite the overall reduction, infants born to black women were 32 times more likely to have syphilis than those born to white mothers. Congenital syphilis rates declined 58 percent among whites and 60 percent among blacks between 1997 and 2000, the CDC said.

"Syphilis disproportionately affects African-Americans living in poverty, primarily in the South and in selected urban areas," said Dr. Judith Wasserheit, director of the CDC's STD prevention program.

Efforts to test all women for syphilis during the early stages of pregnancy have led to the decline in congenital syphilis, researchers said. In areas where syphilis prevalence is high, the CDC recommends that women be tested again during the third trimester of pregnancy and at the time of delivery.

"We can eliminate congenital syphilis from the United States by screening pregnant women for syphilis, and treating them with a single-dose of penicillin, an inexpensive, widely available antibiotic that is effective and safe for both mother and child," said Dr. Helene Gayle, the director of the CDC's Center for HIV, STD and TB Prevention.

During the year 2000, the congenital syphilis rate for blacks was 49.3 cases per 100,000 live births. It was 22.6 cases per 100,000 live births for Hispanics and 1.5 cases per 100,000 live births for whites.

"Elimination of congenital syphilis is a feasible goal because of the limited number of cases and its highly concentrated geographic distribution," said Dr. George Counts, the director of CDC's syphilis elimination program.

The CDC reported last year that the nation's overall syphilis rate was 2.5 cases per 100,000 people in 1999, an 88 percent decline from 1990 and the lowest level since reporting began in 1942.

"History shows that syphilis rates tend to run in 7- to 10-year cycles, so unless we take action to eliminate syphilis now, we could once again experience a rise in syphilis rates," Wasserheit said.

"The way to eliminate congenital syphilis is to eliminate adult syphilis in women of reproductive age," she said.

The disease, once known as "bad blood," is caused by the bacterium Treponema pallidum. It has also been called "the great imitator" because its symptoms are similar to other diseases.

Syphilis also plays a role in the spread of infection with HIV, the virus that causes AIDS. The CDC said the presence of syphilis increases the chances of acquiring and spreading HIV infection at least two- to five-fold.


010712
UP010707


Copyright © 2001 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .